The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

Elon Musk recently had a necessary neck surgery due to a persistent injury from a sumo wrestling incident. Musk, who has undergone multiple surgeries, shared that this operation was painful but ...

LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for recurrent or metastatic head and neck squamous cell carcinoma. The FDA has ...